Can serum orexin levels be used as a marker in childhood epilepsy?
Mutluay Arslan1, Canan Üstün2, Ayşe Nur Coşkun1
1Department of Pediatric Neurology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, the Republic of Türkiye.
Insights
This study found no significant difference in orexin-A levels in pediatric epilepsy patients with active seizures, in remission, or healthy controls. Orexin levels did not correlate with seizure type or timing, suggesting further research is needed for its role in epilepsy.
Area of Science:
- Pediatric Neurology
- Neuroendocrinology
- Epileptology
Background:
- Epilepsy is a common pediatric neurological disorder.
- Orexins are peptides involved in various physiological processes, including arousal and cognition.
- The role of orexins in pediatric epilepsy remains largely unexplored.
Purpose of the Study:
- To investigate the relationship between plasma orexin-A levels and seizure activity in pediatric epilepsy patients.
- To compare orexin-A levels in children with active seizures, epilepsy in remission, and healthy controls.
Main Methods:
- A comparative study involving 30 pediatric epilepsy patients with recent seizures, 30 in remission, and 17 healthy controls.
- Serum orexin-A levels were measured using the Human Orexin-A Enzyme-Linked Immunosorbent Assay Kit.
- Blood samples were collected during routine controls for remission and control groups.
Main Results:
- No statistically significant difference in serum orexin-A levels was observed among the acute seizure, epilepsy in remission, and control groups.
- Orexin-A levels did not differ based on the time of blood sampling post-seizure (0-24 hours).
- No significant differences in orexin-A levels were found when comparing focal versus generalized seizures or based on EEG/MRI findings.
Conclusions:
- This study is the first to assess orexin levels in pediatric epilepsy patients.
- The findings suggest that orexin-A levels may not be directly correlated with seizure activity or type in children.
- Further research is warranted to elucidate the precise role of orexins in epilepsy pathophysiology and potential therapeutic applications.
Objective:
Epilepsy is one of the most common neurological diseases in the pediatric population. Orexins are excitatory peptides and associated with energy homeostasis, eating and drinking behaviors, sleep regulation, sleep-wake periods, analgesia, and cognitive activities such as attention, learning, and memory. The aim of this study was to reveal the relationship between plasma orexin levels and seizures in pediatric epilepsy patients with seizures, epilepsy patients in remission, and healthy control group with similar demographic characteristics.
Material And Methods:
The study was conducted between December 2021 and December 2022 in the Department of Pediatric Neurology of a tertiary hospital. 30 epilepsy patients who had a seizure in the last 24 h, 30 epilepsy patients in remission, and 17 healthy controls were included in the study. The Human Orexin-A Enzyme-Linked Immunosorbent Assay Kit was used to measure serum orexin-A level. In the ERG and CG, blood samples were obtained during routine controls.
Results:
No statistically significant difference was found between serum orexin levels of acute seizure group (ASG), epilepsy in remission group (ERG), and control group (CG). In the ASG, no significant difference was found when orexin levels were compared according to the time of blood sampling after seizure (0-8 h, 8-16 h, 16-24 h). In patients with seizures, the orexin levels of patients with focal seizures were compared with those of patients with generalized seizures. There was no statistically significant difference between the groups. Patients with seizures were evaluated according to electroencephalography (EEG) and cranial magnetic resonance imaging (MRI) findings, and no statistically significant difference was found between orexin levels between the groups.
Conclusion:
Our study is the first to evaluate orexin levels in children with epilepsy. Further research is needed to evaluate the role of orexins in the pathophysiology of epilepsy. With the clear relationship between orexin and epilepsy, antiorexinergic drugs can be used in the treatment of epilepsy.
More Related Videos
Related Concept Videos
01:24Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:24Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:07Narcolepsy